SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $126,000 | +5.0% | 8,373 | -15.0% | 0.00% | – |
| Q1 2016 | $120,000 | -16.1% | 9,856 | +9.4% | 0.00% | – |
| Q4 2015 | $143,000 | -4.7% | 9,006 | -8.2% | 0.00% | – |
| Q3 2015 | $150,000 | -35.1% | 9,815 | +3.1% | 0.00% | – |
| Q2 2015 | $231,000 | +140.6% | 9,519 | +131.2% | 0.00% | – |
| Q1 2015 | $96,000 | -26.2% | 4,118 | -20.6% | 0.00% | – |
| Q4 2014 | $130,000 | +62.5% | 5,189 | +101.7% | 0.00% | – |
| Q3 2014 | $80,000 | +100.0% | 2,573 | +65.3% | 0.00% | – |
| Q2 2014 | $40,000 | -2.4% | 1,557 | -21.6% | 0.00% | – |
| Q3 2013 | $41,000 | – | 1,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |